Table III.
A, Pattern of recurrence. | |||
---|---|---|---|
CCRT-alone (n=20) | CCRT-CTX (n=17) | p-value | |
Recurrence | 8 (40%) | 5 (29%) | |
Locoregional failure | 5 (25%) | 2 (12%) | NS |
Lymph node failure | 4 (20%) | 4 (23%) | NS |
Distant metastasis (excluding para-aortic failure) | 2 (10%) | 1 (6%) | NS |
Inside radiation field | 6 (30%) | 4 (23%) | NS |
Outside radiation field | 3 (15%) | 2 (12%) | NS |
B, Pattern of recurrence of patients who underwent para-aortic lymphadenopathy (n=15). | |||
---|---|---|---|
CCRT-alone (n=4) | CCRT-CTX (n=11) | p-value | |
Recurrence | 3 (75%) | 4 (36%) | NS |
Locoregional failure | 2 | 1 | NS |
Lymph node failure | 2 | 4 | NS |
Distant metastasis (excluding para-aortic failure) | 1 | 3 | NS |
NS, not significant.